Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review

C Russell, TP George, N Chopra, B Le Foll… - The American Journal …, 2024 - Taylor & Francis
Background: Medications for opioid use disorder (MOUD) reduce risks for overdose among
correctional populations. Among other barriers, daily dosing requirements hinder treatment …

[HTML][HTML] Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from …

M Curtis, AL Wilkinson, P Dietze, AC Stewart… - Harm Reduction …, 2023 - Springer
Background A precipitous decline in health status among people recently released from
prison is common. In Victoria, Australia, opioid agonist treatment (OAT) in the community …

Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the …

A Ahmad, DJ Bromberg, R Shrestha… - International Journal of …, 2024 - Elsevier
Background Incarcerated people with HIV and opioid-dependence often experience poor
post-release outcomes in the absence of methadone maintenance treatment (MMT). In a …

[PDF][PDF] Evaluation zum Bedarf nach einer Substitutionsbehandlung von Opioidabhängigen, die gegenwärtig nicht in dieser Behandlung sind

H Zurhold, S Kuhn - zis-hamburg.de
Die Substitutionsbehandlung bzw. Opioidagonistentherapie (OAT) ist eine der wirksamsten
Behandlungsoptionen für Opioidabhängige. Die wissenschaftliche Evidenz belegt, dass …

Endogenous opiates and behavior: 2023

RJ Bodnar - Peptides, 2024 - Elsevier
This paper is the forty-sixth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …